Partners

Business Strategy

Our business strategy is to commercialize pHLIP® technology by developing pHLIP® Drug Conjugates (PDCs) from our pipeline and by partnering with biopharmaceutical companies to enable or improve the safety and efficacy of their imaging agents, drugs or drug candidates.

Partners

Out-Licensing

Integral to our business strategy is proliferation of our technology via multiple partnering and out-licensing in other fields and indications: Please contact us